Retailer Eyes States To Ease Waste Rules On Take-Back Pharmaceuticals

A national retailer expected to be instrumental in facilitating take-back operations for collecting unwanted pharmaceuticals is looking to states to clarify a patchwork of solid and hazardous waste regulations that could impede implementation of a new Drug Enforcement Administration (DEA) rule that generally eases requirements for establishing such collection programs. While DEA has said it will continue to work with EPA on the issue of secure and responsible drug disposal for pharmaceutical controlled substances that may also be considered hazardous...